These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 4209057

  • 1. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB, Lewis RM, Swartz DR, Gump DW.
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract] [Full Text] [Related]

  • 2. Inhaled tobramycin (TOBI).
    Bonsignore CL.
    Pediatr Nurs; 1998 May; 24(3):258-9. PubMed ID: 9987427
    [Abstract] [Full Text] [Related]

  • 3. Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
    Paporisz U, Posselt HG, Wönne R, Ristow W, Röser D, Knothe H, Bender SW.
    Monogr Paediatr; 1979 May; 10():31-3. PubMed ID: 460275
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aminoglycoside antibiotics.
    Axline SG, Galgiani JN.
    Ariz Med; 1979 Jun; 36(6):457-61. PubMed ID: 454223
    [No Abstract] [Full Text] [Related]

  • 7. [Bacteriologic surveillance of the sputum of 22 patients with mucoviscidosis].
    Feigelson J, Pecau Y.
    Arch Fr Pediatr; 1967 Dec; 24(10):1135-47. PubMed ID: 5590823
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Therapy with combinations of aminoglycosides and other antibiotics].
    Stille W.
    Adv Clin Pharmacol; 1978 Dec; 15():127-40. PubMed ID: 676871
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Bacterial infections of the lungs in mucoviscidosis patients].
    Hogardt M, Heesemann J.
    MMW Fortschr Med; 2005 Jan 27; 147(4):38-40. PubMed ID: 15745340
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A, McGaw J, Dalton A, Beal G, Everard M, Taylor CJ.
    J Cyst Fibros; 2006 May 27; 5(2):101-4. PubMed ID: 16426904
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
    Young DC, Zobell JT, Stockmann C, Waters CD, Ampofo K, Sherwin CM, Spigarelli MG.
    Pediatr Pulmonol; 2013 Nov 27; 48(11):1047-61. PubMed ID: 24000183
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
    Geddes DM.
    Chest; 1988 Aug 27; 94(2 Suppl):140S-145S. PubMed ID: 3293940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.